🇺🇸 FDA

Intelligence Platform

Patents

Browse 308 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12060419

CD79A chimeric antigen receptors

REGENERON PHARMACEUTICALS, INC. · Granted Tue Aug 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12053491

Bispecific OR-gate chimeric antigen receptor responsive to CD19 and CD20

The Regents of the University of California · Granted Tue Aug 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12049487

Universal chimeric antigen receptor T-cell preparation technique

GRACELL BIOTECHNOLOGIES (SHANGHAI) CO., LTD. · Granted Tue Jul 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12049510

Chimeric antigen receptor

AUTOLUS LIMITED · Granted Tue Jul 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12042543

Substituted 3-amino-5-phenylbenzamide compounds as covalent inhibitors of enhancer zeste h

Northwestern University · Granted Tue Jul 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12043655

Constitutively active chimeric cytokine receptors

Allogene Therapeutics, Inc. · Granted Tue Jul 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12030953

Chimeric antigen receptors, compositions, and methods

Regents of the University of Minnesota · Granted Tue Jul 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12005081

Chimeric receptors and methods of use thereof

Senti Biosciences, Inc. · Granted Tue Jun 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11999773

Anti-BCMA chimeric antigen receptors

Cartesian Therapeutics, Inc. · Granted Tue Jun 04 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 30 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11999796

Anti-CD70 chimeric antigen receptors

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 04 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 30 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11993660

Chimeric polypeptides and methods of altering the membrane localization of the same

Cell Design Labs, Inc. · Granted Tue May 28 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 23 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11992519

Chimeric antigen receptor (CAR) that targets chemokine receptor CCR4 and its use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 28 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 23 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11981739

Chimeric antigen receptor specific for interleukin-23 receptor

SANGAMO THERAPEUTICS FRANCE · Granted Tue May 14 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11980640

Bicistronic chimeric antigen receptors and their uses

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 14 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11975063

Recombinant chimeric bovine/human parainfluenza virus 3 expressing rsv g and its use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11963981

Chimeric antigen receptor

AUTOLUS LIMITED · Granted Tue Apr 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11951131

Anti-SLAMF7 chimeric antigen receptors

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11944644

T-cells comprising anti-CD38 and anti-CD138 chimeric antigen receptors and uses thereof

The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted Tue Apr 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11931399

Compositions and methods for dengue virus chimeric constructions in vaccines

Takeda Vaccines, Inc. · Granted Tue Mar 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11932698

Anti-mesothelin chimeric antigen receptor (CAR) constructs and uses thereof

Nanjing Legend Biotech Co., Ltd · Granted Tue Mar 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11926676

Masked chimeric antigen receptor specific to tyrosine-protein kinase like 7 (PTK7) and imm

CRISPR THERAPEUTICS AG · Granted Tue Mar 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11896617

Polynucleotides encoding rituximab-resistant chimeric antigen receptors

Allogene Therapeutics, Inc. · Granted Tue Feb 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11890346

Proteolysis-targeting chimeric molecules (PROTACs) that induce degradation of c-MYC protei

Northwestern University · Granted Tue Feb 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11883433

Chimeric antigen receptor comprising anti-mesothelin scFv, and use thereof

CELLENGENE INC. · Granted Tue Jan 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted